Social cognition as an under-used behavioural endpoint in neurodevelopmental psychopharmacology: A conditional framework for integrating theory of mind into clinical trial design.
European journal of pharmacology · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
HumansSocial CognitionTheory of MindNeurodevelopmental DisordersPsychopharmacologyClinical Trials as TopicAnimalsResearch DesignBehavioural pharmacologyClinical outcome assessmentClinical trial endpointsNeurodevelopmental disordersSocial cognitionTheory of mind
Come citare questo studio
Berkan Sahin. (2026). Social cognition as an under-used behavioural endpoint in neurodevelopmental psychopharmacology: A conditional framework for integrating theory of mind into clinical trial design.. European journal of pharmacology. DOI: 10.1016/j.ejphar.2026.179270
Consulta la pubblicazione originale ↗